Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Mar 15, 2026; 18(3): 117278
Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.117278
Published online Mar 15, 2026. doi: 10.4251/wjgo.v18.i3.117278
Table 2 Base case: Health outcomes
| Strategy | Health outcomes (per 100000 participants) | |
| ESCC cases | ESCC deaths | |
| No screening | 3134 | 2409 |
| Sponge cytology screening | ||
| Once | 2962 | 2266 |
| Every 10 years | 2515 | 1874 |
| Every 5 years | 2011 | 1469 |
| Every 3 years | 1510 | 1088 |
| Every 2 years | 1060 | 750 |
| Every year | 373 | 257 |
| Endoscopic screening | ||
| Once | 2943 | 2305 |
| Every 10 years | 2606 | 2006 |
| Every 5 years | 2277 | 1685 |
| Every 3 years | 1867 | 1362 |
| Every 2 years | 1470 | 1052 |
| Every year | 755 | 514 |
- Citation: Xu YS, Gao Y, Jiao YF, Yu CT, Wang W, Wang TL, Chu C, Lin H, Xu JF, Xin L, Wang LW. Cost-effectiveness of sponge cytology test vs endoscopy for esophageal squamous cell carcinoma screening in high-risk areas. World J Gastrointest Oncol 2026; 18(3): 117278
- URL: https://www.wjgnet.com/1948-5204/full/v18/i3/117278.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i3.117278